Skip to main content

Table 2 Diagnostic test and clinical data

From: Clinical and laboratory markers defining MIS-C and hyperinflammation in COVID-19: a cross-sectional study in a tertiary hospital

Variables

Sample (54 Patients)

MIS-C (31 Patients)

Hyperinflammation (23 Patients)

p-value

Diagnostic test

< 0.001

 RT-PCR – nº (%)

 

  - Positive

37 (69)

14 (45)

23 (100)

  - Negative

17 (32)

17 (55)

-

 COVID Serology – nº (%)

 

0.14

  - Positive

   

   IgG positive

17 (32)

17 (55)

-

   IgG and IgM positive

6 (11)

4 (13)

2 (9)

Clinical signs and symptoms – nº (%)

 

 - Fever

52 (96)

31 (100)

21 (91)

0.2

 - Abdominal pain

35 (65)

23 (74)

12 (52)

0.094

 - Cough

24 (44)

11 (35)

13 (57)

0.12

 - Dermatological *

29 (55)

13 (43)

16 (70)

0.057

 - Diarrhea

21 (39)

15 (48)

6 (26)

0.1

 - Cardiological **

19 (35)

15 (48)

4 (17)

0.018

 - Rhinorrhea

18 (33)

11 (35)

7 (30)

0.7

 - Odynophagia

12 (22)

4 (13)

8 (35)

0.056

 - Respiratory dysfunction

17 (32)

4 (13)

13 (57)

< 0.001

 - Myocarditis

3 (6)

3 (10)

-

0.3

 - Vomiting

15 (28)

10 (32)

5 (22)

0.4

 - Headache

10 (19)

7 (23)

3 (13)

0.5

 - Serositis

4 (7)

4 (13)

-

0.13

 - Conjunctival hyperemia

10 (19)

9 (29)

1 (4)

0.032

 - Arthritis/arthralgia

8 (15)

7 (23)

1 (4)

0.12

 - Neurological***

25 (46)

19 (61)

6 (26)

0.014

 # Other

38 (70)

28 (90)

10 (43)

< 0.001

  1. Nº Number of patients, % relative to the total population described
  2. * Diffuse erythematous rash or oral ulcer
  3. ** Hypotension, signs of low flow or heart rate alteration
  4. *** Altered mental status
  5. # Peeling of extremities, presence of stridor, aneurysms, bone marrow aplasia, loss of smell/taste, appendicitis, pancreatitis, Guillain-Barré syndrome